It has been confirmed that using anti‐TNF‐α blockers can be a probable way to help depression in unresponsive patients with PSD (Karson et al., 2013; Ma et al., 2016), where common therapies like SSRIs have shown higher levels of TNF‐α in before and posttreatment (Ma et al., 2016). Here, TNF is linked to depressive disorder.